聚焦超声介导液体活检在tau蛋白病小鼠模型中的可行性研究
本研究在tau蛋白病转基因小鼠(PS19)中评估聚焦超声介导液体活检(sonobiopsy)检测脑源性蛋白生物标志物的可行性与安全性。优化参数后未观察到治疗侧半球微出血增加,表明sonobiopsy可安全释放tau蛋白和神经退行性标志物入血。
要点
- Sonobiopsy可提高血浆p-tau和NfL检出水平,为神经退行性疾病提供无创诊断途径。
- 空间靶向sonobiopsy(海马或皮层)可成功释放脑源性蛋白入血。
- 优化参数后未观察到明显组织损伤或微出血增加,安全性可控。
关键影像表现/征象
- 优化sonobiopsy参数后,治疗侧大脑半球与对侧相比未观察到过多微出血。
局限性
- 研究仅在小鼠模型中进行,结果向人类临床转化需进一步验证。
- 样本量较小,统计效能有限。
- 未报告sonobiopsy的长期安全性数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Neurodegenerative disorders (such as Alzheimer disease) characterized by the deposition of various pathogenic forms of tau protein in the brain are collectively referred to as tauopathies. Identification of the molecular drivers and pathways of neurodegeneration is critical to individualized targeted treatment of these disorders. However, despite important advances in fluid biomarker detection, characterization of these molecular subtypes is limited by the blood-brain barrier. Purpose To evaluate the feasibility and safety of focused ultrasound-mediated liquid biopsy (sonobiopsy) in the detection of brain-derived protein biomarkers in a transgenic mouse model of tauopathy (PS19 mice). Materials and Methods Sonobiopsy was performed by sonicating the cerebral hemisphere in 2-month-old PS19 and wild-type mice, followed by measurement of plasma phosphorylated tau (p-tau) species (30 minutes after sonication in the sonobiopsy group). Next, spatially targeted sonobiopsy was performed by sonicating either the cerebral cortex or the hippocampus in 6-month-old PS19 mice. To detect changes in plasma neurofilament light chain (a biomarker of neurodegeneration) levels, blood samples were collected before and after sonication (15 and 45-60 minutes after sonication). Histologic staining was performed to evaluate tissue damage after sonobiopsy. The Shapiro-Wilk test, unpaired and paired t tests, and the Mann-Whitney U test were used. Results In the 2-month-old mice, sonobiopsy significantly increased the normalized levels of plasma p-tau species compared with the conventional blood-based liquid biopsy (p-tau-181-to-mouse tau [m-tau] ratio: 1.7-fold increase, P = .006; p-tau-231-to-m-tau ratio: 1.4-fold increase, P = .048). In the 6-month-old PS19 mice, spatially targeted sonobiopsy resulted in a 2.3-fold increase in plasma neurofilament light chain after sonication of the hippocampus and cerebral cortex (P < .001). After optimization of the sonobiopsy parameters, no excess microhemorrhage was observed in the treated cerebral hemisphere compared with the contralateral side. Conclusion This study showed the feasibility of sonobiopsy to release phosphorylated tau species and neurofilament light chain to the blood circulation, potentially facilitating diagnosis of neurodegenerative disorders. © RSNA, 2023 Supplemental material is available for this article. See also the editorial by Fowlkes in this issue.
引用
- Pacia, Yuan, Yue, et al. Focused Ultrasound-mediated Liquid Biopsy in a Tauopathy Mouse Model. Radiology. 2023. PMID: 36719290. doi:10.1148/radiol.220869
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。